Background illustration for clinical trials search

Paid Clinical Trials New York City

Discover 4,033 paid clinical trials in New York City, New York. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

An Open-Label Pilot Study of VTX2735 in Recurrent Pericarditis

for
Recurrent Pericarditis
Location: New York NY, Boston MA, Burlington VT, Richmond VA,
Sponsor: Zomagen Biosciences Ltd.

Sex: All

Age: 18 - 70+

Code: NCT06836232

Phase2, Recruiting
New

Incretin Therapies in Obesity-related HFpEF

for
Heart Failure, Diastolic,
Location: New York NY
Sponsor: Columbia University

Sex: All

Age: 40+

Code: NCT07554638

Recruiting

Trifecta-Heart cfDNA-MMDx Study

for
Heart Transplant Rejection
Location: West New York NJ, The Bronx NY, Tampa FL,
Sponsor: University of Alberta

Sex: All

Age: 0+

Code: NCT04707872

Recruiting

Trifecta-Lung cfDNA-MMDx Study

for
Lung Transplantation
Location: New York NY, Baltimore MD, Toronto, Columbus OH,
Sponsor: University of Alberta

Sex: All

Age: 18+

Code: NCT05837663

Recruiting

A Study of Amivantamab Monotherapy and in Addition to Standard-of-Care Chemotherapy in Participants With Advanced or Metastatic Colorectal Cancer

for
Advanced or Metastatic Colorectal Cancer
Location: New York NY, Ottawa, Toronto, Ann Arbor MI,
Sponsor: Janssen Research & Development, LLC

Sex: All

Age: 18+

Code: NCT05379595

Phase1, Phase2, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Personalized Antibody-Drug Conjugate Therapy Based on RNA and Protein Testing for the Treatment of Advanced or Metastatic Solid Tumors (The ADC MATCH Screening and Treatment Trial)

for
Advanced Malignant Solid Neoplasm,
Location: New York NY, Trumbull CT, New Haven CT, Boston MA,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT06311214

Phase2, Recruiting

SAD and MAD of Inhaled AR-501 in Health Adults and P. Aeruginosa Infected Cystic Fibrosis Subjects

for
Cystic Fibrosis
Location: New York NY, Philadelphia PA, Baltimore MD, Portland ME,
Sponsor: Aridis Pharmaceuticals, Inc.

Sex: All

Age: 18 - 49

Code: NCT03669614

Phase1, Phase2, Recruiting

Paclitaxel Coated Balloon for the Treatment of Chronic bEnigN sTricture- Esophagus

for
Esophageal Stricture
Location: New York NY, Piscataway NJ, Philadelphia PA, Boston MA,
Sponsor: GIE Medical

Sex: All

Age: 22+

Code: NCT05561114

Phase3, Recruiting

A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)

for
Leukemia, Myeloid, Acute, Leukemia, Lymphocytic, Acute,
Location: Morristown NJ, New Brunswick NJ, Philadelphia PA,
Sponsor: Sumitomo Pharma America, Inc.

Sex: All

Age: 12+

Code: NCT04988555

Phase1, Phase2, Recruiting

Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors

for
Colorectal Carcinoma, Endometrial Carcinoma, Melanoma,
Location: New York NY, Philadelphia PA, Boston MA,
Sponsor: Children's Oncology Group

Sex: All

Age: 1 - 30

Code: NCT04851119

Phase1, Phase2, Recruiting

Study Adding Drugs to Usual Treatment for Large B-Cell Lymphoma That Returned or Did Not Respond to Treatment

for
Grade 3b Follicular Lymphoma, High Grade B-Cell Lymphoma,
Location: New York NY, Webster NY, Rochester NY, Richmond VA,
Sponsor: SWOG Cancer Research Network

Sex: All

Age: 18+

Code: NCT05890352

Phase2, Recruiting

Multi-site Study for Evaluation of Clinical Ranges of Whole Blood Clotting Times of Patients on Anticoagulants and Verification of Measurement Precision of Liquid Quality Controls With the Perosphere Technologies' PoC Coagulometer

for
Coagulation
Location: Danbury CT, White Plains NY, Rockville MD,
Sponsor: Sciema UG

Sex: All

Age: 18 - 70+

Code: NCT04868214

Recruiting

A Study to Find the Highest Dose of Imetelstat in Combination With Fludarabine and Cytarabine for Patients With AML, MDS or JMML That Has Come Back or Does Not Respond to Therapy

for
Recurrent Childhood Acute Myeloid Leukemia,
Location: New York NY, Philadelphia PA, Boston MA,
Sponsor: Children's Oncology Group

Sex: All

Age: 1 - 18

Code: NCT06247787

Phase1, Recruiting
New

Temporally-Modulated Pulsed Radiation Therapy Versus Standard Radiation Therapy for the Treatment of Newly Diagnosed, IDH Wildtype, MGMT-Unmethylated Glioblastoma

for
Glioblastoma, IDH-Wildtype, MGMT-Unmethylated Glioblastoma
Location: New York NY, The Bronx NY, Bel Air MD, Baltimore MD,
Sponsor: NRG Oncology

Sex: All

Age: 18+

Code: NCT07452458

Phase3, Recruiting

Evaluation of Eflornithine Plus Temozolomide in Patients With Newly Diagnosed Glioblastoma or Astrocytoma

for
Glioblastoma, IDH-wildtype, Glioblastoma,
Location: New York NY, Providence RI, Cleveland OH, Durham NC,
Sponsor: Orbus Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT05879367

Phase1, Recruiting

A Study of Pembrolizumab (MK-3475) in Pediatric Participants With an Advanced Solid Tumor or Lymphoma (MK-3475-051/KEYNOTE-051)

for
Melanoma, Lymphoma, Solid Tumor, Classical Hodgkin Lymphoma,
Location: New York NY, Boston MA, Chicago IL, Sioux Falls SD,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 0 - 17

Code: NCT02332668

Phase1, Phase2, Recruiting

Evaluate the Safety of DEXYCU for the Treatment of Inflammation Following Ocular Surgery for Childhood Cataract

for
Cataract
Location: New York NY, Omaha NE, Buffalo NY, Boston MA,
Sponsor: EyePoint Pharmaceuticals, Inc.

Sex: All

Age: 0 - 3

Code: NCT05191706

Recruiting

Study of Momelotinib in Combination With Luspatercept in Participants With Transfusion Dependent Myelofibrosis

for
Primary Myelofibrosis,
Location: New York NY, Toronto, Montreal, Ann Arbor MI,
Sponsor: GlaxoSmithKline

Sex: All

Age: 18+

Code: NCT06517875

Phase2, Recruiting
New

A Sequential Phase 2/3 Study of APL2 in Patients With Focal Segmental Glomerulosclerosis

for
FSGS
Location: New York NY, Chicago IL
Sponsor: Apellis Pharmaceuticals, Inc.

Sex: All

Age: 18+

Code: NCT07213960

Phase2, Phase3, Recruiting

EFS of the DUO System for Tricuspid Regurgitation

for
Tricuspid Regurgitation, Tricuspid Valve Insufficiency,
Location: New York NY, Harrisburg PA, Columbus OH, Chicago IL,
Sponsor: CroiValve Limited

Sex: All

Age: 18+

Code: NCT05913908

Recruiting

New York City stands out as a location known for a diverse array of clinical trials, thanks to its extensive healthcare network and renowned medical research institutions. Leading centers such as Memorial Sloan Kettering Cancer Center, NYU Langone Health, Mount Sinai Health System, and Weill Cornell Medicine are at the forefront of pioneering studies across various fields. The city's rich combination of cutting-edge research facilities and a diverse population enhances the scope and impact of clinical trials conducted here.

Why choose New York City for clinical trials?

New York City is an exceptional choice for participating in clinical trials, renowned for its innovative research environment and strong emphasis on groundbreaking medical advancements, with prestigious institutions such as Memorial Sloan Kettering Cancer Center, NYU Langone Health, and Mount Sinai Health System at the forefront.

By participating in a clinical trial in New York City, you not only gain early access to cutting-edge treatments but also contribute to significant medical research that could shape future healthcare practices.

Common conditions studied in New York City

Local regulations and guidelines

Benefits of participating in clinical trials

How to enroll in a clinical trial in New York City